Colin D. Marchant, MD
Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Infectious Diseases

MD, McGill University
BSc, Acadia University

Colin D Marchant, MD, is Director of the Pediatric Vaccine Research Center and the Principle Investigator of the Clinical Immunization Safety Assessment Center at Boston Medical Center. Dr. Marchant is also an Adjunct Associate Professor of Pediatrics at the Chobanian and Avedisian School of Medicine and Associate Professor of Pediatrics at the Tufts University School of Medicine. He graduated from Acadia University in Nova Scotia and received his medical degree from McGill University in Montreal. Dr. Marchant completed his residency in the Department of Medicine at McMaster University in Hamilton, Ontario, and was chief resident in Pediatrics at the Cleveland Metropolitan General Hospital in Cleveland, Ohio. Dr. Marchant is board-certified in pediatrics and pediatric infectious diseases. He has written numerous original articles, book chapters, and reviews.

A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of a human monoclonal antibody, REGN2222, for the prevention of medically attended RSV infection in
12/23/2015 - 06/17/2017 (PI)
Regeneron Pharmaceuticals, Inc.

A Safety and Immunogenicity Study of Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle Vaccine in Preadolescents and Adolescents
10/01/2003 - 12/31/2016 (PI)
Merck & Company, Inc.

A phase II, observer-blind, randomized, controlled, multi-centre study to evaluate the immunogenicity and safety of GSK Biologicals quadrivalent influenza vaccine candidate
10/23/2013 - 09/30/2016 (PI)
GlaxoSmithKline LLC

A Phase III Double Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of VARIVAX New Seed Process (NSP) Administered Concomitantly with M-M-R II
08/04/2014 - 08/03/2016 (PI)
Merck, Sharp & Dohme LLC

A phase IIIb, open, randomized, controlled, multicenter study to assess the co-administration of Rotarix (GlaxoSmithKline Biologicals') with Hib-MenCY-TT
07/01/2013 - 06/30/2016 (PI)
GlaxoSmithKline LLC

A phase IIIA, randomized, observer-blind, controlled, multinational study to evaluate the safety and immunogenicity of GSK Biologicals' MMR vaccine (209762)
08/15/2014 - 07/31/2015 (PI)
GlaxoSmithKline LLC

A phase IIIA, blinded randomized controlled multinational consistency study to evaluate the immunogenicity and safety of GSK Biologicals' MMR Vaccine (209762) compared to Merck's
10/01/2012 - 06/30/2015 (PI)
GlaxoSmithKline LLC

Immunogenicity and Safety of GSK Biologicals' Combined Measles-Mumps-Rubella Vaccine in Subjects Four to Six Years of Age
07/01/2012 - 06/30/2015 (PI)
GlaxoSmithKline LLC

A Phase III Double blind, randomized, multicenter, controlled study to evaluate the safety, tolerability and immunogenicity of measles, mumps, rubella, varicella (MMRV) vaccine made with an alternativ
07/01/2012 - 06/30/2015 (PI)
Merck & Company, Inc.

A Phase 3, Open-label, Randomized, Parallel-group, Multi-center Study to Evaluate the Safety and Immunogenecity of Novartis Meningococcal ACWY Conugate Vaccine when Administered with Routine Infant Va
11/19/2008 - 11/18/2013 (PI)
Novartis Vaccines and Diagnostics, Inc.

Showing 10 of 45 results. Show All Results

Assessing Rates of Fever and Other Adverse Events in Children after US Influenza Vaccines Using Text
09/19/2014 - 09/18/2016 (PI)

Clinical Immunization Safety Assessment Safety (CISA) Center
09/29/2012 - 09/28/2013 (PI)

A double-blind, randomized controlled phase III study
01/12/2004 - 03/31/2013 (PI)
St. Louis University NIH

Vaccine Safety - CISA
09/01/2002 - 09/29/2012 (PI)
America's Health Insurance Plans CDC

Vaccine Safety - CISA: Phase I H1N1 funding
07/01/2010 - 06/30/2011 (PI)
America's Health Insurance Plans CDC

Clinical Immunization Safety A
09/30/2001 - 09/29/2004 (PI)


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Stockwell MS, Marchant CD, Wodi AP, Barnett ED, Broder KR, Jakob K, Lewis P, Kattan M, Rezendes AM, Barrett A, Sharma D, Fernandez N, LaRussa P. A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging. Vaccine. 2017 12 15; 35(50):6941-6948.View Related Profiles. PMID: 29089191; PMCID: PMC6693331; DOI: 10.1016/j.vaccine.2017.10.073;
  2. Loughlin AM, Hsu K, Silverio AL, Marchant CD, Pelton SI. Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts' children. Pediatr Infect Dis J. 2014 May; 33(5):504-10.View Related Profiles. PMID: 24670957; DOI: 10.1097/INF.0000000000000279;
  3. Marshall GS, Blatter M, Marchant C, Aris E, Mesaros N, Miller JM. Antibody persistence for up to 5 years after a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) given at 12-15 months of age. Pediatr Infect Dis J. 2013 Jun; 32(6):662-8. PMID: 23340564; DOI: 10.1097/INF.0b013e3182840e35;
  4. Williams SE, Edwards KM, Baxter RP, LaRussa PS, Halsey NA, Dekker CL, Vellozzi C, Marchant CD, Donofrio PD, Reimschisel TE, Berger M, Gidudu JF, Klein NP. Comprehensive assessment of serious adverse events following immunization by health care providers. J Pediatr. 2013 Jun; 162(6):1276-81, 1281.e1. PMID: 23452584; PMCID: PMC7125713; DOI: 10.1016/j.jpeds.2013.01.028;
  5. Pahud BA, Williams SE, Dekker CL, Halsey N, Larussa P, Baxter RP, Klein NP, Marchant CD, Sparks RC, Jakob K, Aukes L, Swope S, Barnett E, Lewis P, Berger M, Dreskin SC, Donofrio PD, Sejvar JJ, Slade BA, Gidudu J, Vellozzi C, Edwards KM. Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination. Pediatr Infect Dis J. 2013 Feb; 32(2):163-8.View Related Profiles. PMID: 23334340; DOI: 10.1097/INF.0b013e318271b90a;
  6. Loughlin AM, Marchant CD, Adams W, Barnett E, Baxter R, Black S, Casey C, Dekker C, Edwards KM, Klein J, Klein NP, LaRussa P, Sparks R, Jakob K. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2012 Nov 26; 30(50):7253-9.View Related Profiles. PMID: 23063829; DOI: 10.1016/j.vaccine.2012.09.074;
  7. Bryant K, McVernon J, Marchant C, Nolan T, Marshall G, Richmond P, Marshall H, Nissen M, Lambert S, Aris E, Mesaros N, Miller J. Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials. Hum Vaccin Immunother. 2012 Aug; 8(8):1036-41. PMID: 22617844; PMCID: PMC3551873; DOI: 10.4161/hv.20357;
  8. Rowhani-Rahbar A, Klein NP, Dekker CL, Edwards KM, Marchant CD, Vellozzi C, Fireman B, Sejvar JJ, Halsey NA, Baxter R. Biologically plausible and evidence-based risk intervals in immunization safety research. Vaccine. 2012 Dec 17; 31(1):271-7. PMID: 22835735; DOI: 10.1016/j.vaccine.2012.07.024;
  9. Halsey NA, Edwards KM, Dekker CL, Klein NP, Baxter R, Larussa P, Marchant C, Slade B, Vellozzi C. Algorithm to assess causality after individual adverse events following immunizations. Vaccine. 2012 Aug 24; 30(39):5791-8. PMID: 22507656
  10. Cherry JD, Tan T, Wirsing von König CH, Forsyth KD, Thisyakorn U, Greenberg D, Johnson D, Marchant C, Plotkin S. Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis. 2012 Jun; 54(12):1756-64. PMID: 22431797; PMCID: PMC3357482; DOI: 10.1093/cid/cis302;
Showing 10 of 72 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 72 publications over 29 distinct years, with a maximum of 7 publications in 2011


Contact for Mentoring:

670 Albany St Biosquare III
Boston MA 02118
Google Map

Marchant's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department